Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cibus Inc CBUS

Healthcare Biotechnology
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant... see more

Recent & Breaking News (NDAQ:CBUS)

Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

PR Newswire February 15, 2023

SHAREHOLDER ALERT: Weiss Law Reminds CLXT, BRBW, MPB, and COUP Shareholders About Its Ongoing Investigations

PR Newswire January 20, 2023

CALYXT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. - CLXT

Business Wire January 19, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, HZN, CLXT, VLTA

PR Newswire January 19, 2023

ALERT: The M&A Class Action Firm Announces the Investigation of Calyxt, Inc. - CLXT

PR Newswire January 18, 2023

Shareholder Alert: Ademi LLP investigates whether Calyxt, Inc. has entered into a Fair Transaction with Cibus

PR Newswire January 18, 2023

SHAREHOLDER ALERT: Weiss Law Investigates Calyxt, Inc.

PR Newswire January 17, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Calyxt, Inc. Merger

Newsfile January 17, 2023

CLXT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Calyxt, Inc. Is Fair to Shareholders

Business Wire January 17, 2023

Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement

GlobeNewswire January 17, 2023

Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company

PR Newswire January 17, 2023

Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil

PR Newswire November 18, 2022

Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

PR Newswire November 17, 2022

Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update

PR Newswire November 3, 2022

Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing

PR Newswire November 1, 2022

Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time

PR Newswire October 27, 2022

Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

PR Newswire October 25, 2022

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

PR Newswire October 6, 2022

Calyxt, Inc. Exploring Strategic Alternatives

PR Newswire September 22, 2022

Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

PR Newswire September 7, 2022